Zepbound vs Saxenda
A side-by-side look at two weight management medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Zepbound | US Saxenda |
|---|---|---|
| Generic name | tirzepatide Unverified catalogue summary (Generic name) for Zepbound in US; not checked against current local product information. | liraglutide Unverified catalogue summary (Generic name) for Saxenda in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Zepbound in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Saxenda in US; not checked against current local product information. |
| Treats | Chronic weight management, obstructive sleep apnea Unverified catalogue summary (Treats) for Zepbound in US; not checked against current local product information. | Chronic weight management Unverified catalogue summary (Treats) for Saxenda in US; not checked against current local product information. |
| Category | Weight Management Unverified catalogue summary (Category) for Zepbound in US; not checked against current local product information. | Weight Management Unverified catalogue summary (Category) for Saxenda in US; not checked against current local product information. |
| Manufacturer | Eli Lilly Unverified catalogue summary (Manufacturer) for Zepbound in US; not checked against current local product information. | Novo Nordisk Unverified catalogue summary (Manufacturer) for Saxenda in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Zepbound in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Saxenda in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Zepbound in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Saxenda in US; not checked against current local product information. |
| Est. TV ad spend | $300M | — |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Zepbound in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Saxenda in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Zepbound or Saxenda better?
This directory does not compare clinical effectiveness or safety. Listing Zepbound and Saxenda together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Zepbound and Saxenda?
The table shows catalogue identification and estimated advertising information for Zepbound and Saxenda, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Zepbound has the larger estimated TV advertising budget of the two.